The present study shows the independent predictive effect of miR-629-3p on lung metastasis in TNBC and reveals that the suppression of miR-629-3p attenuates pulmonary metastasis in experimental breast cancer by directly targeting LIFR, which is an inhibitor of multiple metastatic signaling pathways. Here, LIFR is linked to breast carcinoma.